Malignant neoplasm of upper respiratory tract, part unspecified
- C39.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Malignant neoplasm of upper respiratory tract, part unsp
- The 2024 edition of ICD-10-CM C39.0 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C39.0 – other international versions of ICD-10 C39.0 may differ.
The following code(s) above C39.0 contain annotation back-references
that may be applicable to C39.0:
- C00-D49 Neoplasms
- C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
- C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
Approximate Synonyms
- Cancer of the upper respiratory tract
- Primary malignant neoplasm of upper respiratory tract
ICD-10-CM C39.0 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
- 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
- 013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
- 146 Ear, nose, mouth and throat malignancy with mcc
- 147 Ear, nose, mouth and throat malignancy with cc
- 148 Ear, nose, mouth and throat malignancy without cc/mcc
Convert C39.0 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change